These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27409720)

  • 1. Classics in Chemical Neuroscience: Methylphenidate.
    Wenthur CJ
    ACS Chem Neurosci; 2016 Aug; 7(8):1030-40. PubMed ID: 27409720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential.
    Connor DF; Steingard RJ
    CNS Drugs; 2004; 18(14):1011-30. PubMed ID: 15584770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
    Schweren LJ; de Zeeuw P; Durston S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Groenman AP; Schweren LJ; Dietrich A; Hoekstra PJ
    Expert Opin Drug Saf; 2017 Apr; 16(4):455-464. PubMed ID: 28277842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
    Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder.
    Coetzee M; Kaminer Y; Morales A
    Subst Abus; 2002 Sep; 23(3):165-9. PubMed ID: 12444349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate: its pharmacology and uses.
    Challman TD; Lipsky JJ
    Mayo Clin Proc; 2000 Jul; 75(7):711-21. PubMed ID: 10907387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New therapeutic options in the treatment of attention deficit/hyperactivity disorder].
    Artigas Pallares J
    Rev Neurol; 2004 Feb; 38 Suppl 1():S117-23. PubMed ID: 15011165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
    Shmueli D; Gross-Tsur V
    Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmethylphenidate for attention deficit hyperactivity disorder.
    Coury D
    Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current pharmacotherapy of attention deficit hyperactivity disorder.
    Reddy DS
    Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder.
    Teicher MH; Polcari A; Anderson CM; Andersen SL; Lowen SB; Navalta CP
    J Child Adolesc Psychopharmacol; 2003; 13(1):41-51. PubMed ID: 12804125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 19. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate treatment.
    Weber P; Lütschg J
    Pediatr Neurol; 2002 Apr; 26(4):261-6. PubMed ID: 11992752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.